Analytical Data
-
基因名
AGA
- Application
-
别名
AGA；N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P20933
-
表达区间
24-346aa
-
氨基酸序列
MGSSHHHHHHSSGLVPRGSHMGSSSPLPLVVNTWPFKNATEAAWRALASG GSALDAVESGCAMCEREQCDGSVGFGGSPDELGETTLDAMIMDGTTMDVG AVGDLRRIKNAIGVARKVLEHTTHTLLVGESATTFAQSMGFINEDLSTTA SQALHSDWLARNCQPNYWRNVIPDPSKYCGPYKPPGILKQDIPIHKETED DRGHDTIGMVVIHKTGHIAAGTSTNGIKFKIHGRVGDSPIPGAGAYADDT AGAAAATGNGDILMRFLPSYQAVEYMRRGEDPTIACQKVISRIQKHFPEF FGAVICANVTGSYGAACNKLSTFTQFSFMVYNSEKNQPTEEKVDCI
-
分子量
37 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant E.coli AST2 Protein，His
Cat：PA1000-9117
Recombinant Human BLVRB Protein，His
Cat：PA1000-338DB
Protein Description
AGA (Adenylate Glycolytic Enzyme) recombinant protein research has gained significant interest due to its potential applications in biotechnology and medicine. AGA plays a crucial role in purine metabolism, and its dysfunction is associated with various metabolic disorders, highlighting its importance in understanding and treating such conditions. The ability to produce AGA in recombinant form allows for in-depth studies on its structure and function, enabling researchers to elucidate its biochemical pathways and interactions within cellular systems. The development of AGA recombinant proteins also paves the way for innovative therapeutic approaches, including enzyme replacement therapies for patients with enzymatic deficiencies. Furthermore, the generation of large quantities of pure AGA can facilitate drug discovery processes, as these proteins serve as vital tools in high-throughput screening and assay development. The advancement of techniques like CRISPR and synthetic biology also enhances the capacity for engineering AGA to improve its efficacy or to create novel variants with tailored properties, further expanding its utility in various scientific domains. Overall, AGA recombinant protein research not only contributes to our fundamental understanding of metabolic processes but also holds promise for developing targeted treatments for metabolic disorders, making it a vital area of interest in contemporary biological research.
